Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Taylor Ripley

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|January 10, 2021
Commentary: Interleukin 2: The gasoline that lit the immunotherapeutic fireR Taylor Ripley
Seminars in Thoracic and Cardiovascular Surgery|September 1, 2021
Commentary: Limitations of Data for Primary Pericardial MesotheliomaR Taylor Ripley
Seminars in Thoracic and Cardiovascular Surgery|April 20, 2021
Commentary: To Preserve or Not Preserve (The Lung): That Is the MPM QuestionR Taylor Ripley
JTCVS Techniques|July 28, 2021
Commentary: Keep swinging for the fence-some patients will surviveR Taylor Ripley
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2019
Commentary: Minimally-invasive thymectomy with minimal concernsR Taylor Ripley
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2020
Commentary: Drawing the target after shooting the arrow: The importance of trial designR Taylor Ripley
Thoracic Surgery Clinics|October 5, 2020
Extended Pleurectomy and Decortication for Malignant Pleural MesotheliomaR Taylor Ripley
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2020
Commentary: Filling up my truck from an oil tanker: Can big 'omic' data influence our clinical decisions?R Taylor Ripley
The Journal of Thoracic and Cardiovascular Surgery|October 15, 2019
Reply: Perioperative transfusion: Immunological beast or scapegoatR Taylor Ripley
JTCVS Open|August 25, 2022
Commentary: Immuno-chemo-radio-therapy before esophagectomy: Our next standard?R Taylor Ripley
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Thoracic and Cardiovascular Surgery|January 10, 2021
Commentary: Interleukin 2: The gasoline that lit the immunotherapeutic fireR Taylor Ripley
Seminars in Thoracic and Cardiovascular Surgery|September 1, 2021
Commentary: Limitations of Data for Primary Pericardial MesotheliomaR Taylor Ripley
Seminars in Thoracic and Cardiovascular Surgery|April 20, 2021
Commentary: To Preserve or Not Preserve (The Lung): That Is the MPM QuestionR Taylor Ripley
JTCVS Techniques|July 28, 2021
Commentary: Keep swinging for the fence-some patients will surviveR Taylor Ripley
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2019
Commentary: Minimally-invasive thymectomy with minimal concernsR Taylor Ripley
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2020
Commentary: Drawing the target after shooting the arrow: The importance of trial designR Taylor Ripley
Thoracic Surgery Clinics|October 5, 2020
Extended Pleurectomy and Decortication for Malignant Pleural MesotheliomaR Taylor Ripley
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2020
Commentary: Filling up my truck from an oil tanker: Can big 'omic' data influence our clinical decisions?R Taylor Ripley
The Journal of Thoracic and Cardiovascular Surgery|October 15, 2019
Reply: Perioperative transfusion: Immunological beast or scapegoatR Taylor Ripley
JTCVS Open|August 25, 2022
Commentary: Immuno-chemo-radio-therapy before esophagectomy: Our next standard?R Taylor Ripley
Pageof 11